Clinical Trials Directory

Trials / Completed

CompletedNCT06681597

Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans

The Effect of Raspberry Ketone Intake on Plasma FGF21 Levels

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Nanchang University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

To investigate the molecular mechanism of raspberry ketone on regulating obesity, the investigators studied the effect of raspberry ketone intake on FGF21 in plasma. The age of the volunteers were 18-60 years old, both male and female, without diabetes, hypertension and other diseases. After ingestion of raspberry ketone (500mg), 2ml of blood was collected at 0 hours, 3 hours and 6 hours , and the FGF21 content in plasma was measured using a commercial reagent kit. In addition, the investigators also studied the effect of raspberry ketone intake on energy metabolism 0 hours, 0.5 hours, 3 hours and 6 hours after consuming raspberry ketone (500mg).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRaspberry ketoneHuman consumed 500mg of raspberry ketone

Timeline

Start date
2024-01-10
Primary completion
2024-05-15
Completion
2024-06-01
First posted
2024-11-08
Last updated
2024-11-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06681597. Inclusion in this directory is not an endorsement.